Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $8.9M $11.6M $10.2M $9.8M $18.7M $13.5M $9.9M $12.3M
Accounts Receivable
Inventory
Total Current Assets $28.1M $20.9M $24.7M $33.4M $19.3M $13.8M $12.2M $15.7M
Property, Plant & Equipment $121.5K $88.7K $112.9K $78.1K $65.2K $52.2K $94.5K $123.6K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $28.3M $21.0M $24.8M $33.5M $19.6M $14.9M $13.7M $16.2M
Liabilities
Accounts Payable
Total Current Liabilities
Long-Term Debt
Total Liabilities $11.5M $4.0M $6.0M $7.0M $6.9M $5.4M $3.0M $5.8M
Stockholders' Equity
Retained Earnings $-140.3M $-115.0M $-105.7M $-91.3M $-72.8M
Total Stockholders' Equity $16.8M $17.1M $18.8M $26.6M $12.6M $9.5M $10.7M $10.4M
← Newer Page 2 of 4 Older →